CVE-2018-14789: Philips Intellispace Cardiovascular

Medium severity, CVSS 6.7. EPSS: 0.4% chance of exploitation in the next 30 days.

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

Affected products

• Philips Intellispace Cardiovascular: up to and including 3.1
• Philips Xcelera: up to and including 4.1

Published 2018-08-22. Last modified 2026-06-17.